1. Sandsmark, Elise, Andersen, Maria K, Bofin, Anna M, Rye, Morten B, Tessem, May-Britt. 2017. SFRP4 gene expression is increased in aggressive prostate cancer. In Scientific reports, 7, 14276. doi:10.1038/s41598-017-14622-3. https://pubmed.ncbi.nlm.nih.gov/29079735/
2. Chen, Yue, Li, Zhi-Yong, Zhou, Guan-Qun, Sun, Ying. 2020. An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma. In Clinical cancer research : an official journal of the American Association for Cancer Research, 27, 330-341. doi:10.1158/1078-0432.CCR-20-2166. https://pubmed.ncbi.nlm.nih.gov/33097495/
3. Durham, Emily L, Grey, Zachary J, Black, Laurel, Lee, Beth S, Cray, James J. 2022. Sfrp4 expression in thyroxine treated calvarial cells. In Life sciences, 311, 121158. doi:10.1016/j.lfs.2022.121158. https://pubmed.ncbi.nlm.nih.gov/36370870/
4. Bérubé, Michael, Abedini, Atefeh, Lapointe, Evelyne, Zamberlam, Gustavo, Boerboom, Derek. 2024. SFRP4 promotes autophagy and blunts FSH responsiveness through inhibition of AKT signaling in ovarian granulosa cells. In Cell communication and signaling : CCS, 22, 396. doi:10.1186/s12964-024-01736-1. https://pubmed.ncbi.nlm.nih.gov/39138534/
5. Guo, Liwen, Chen, Huihua, Chen, Jinguo, Chen, Zichun, Cao, Luoyuan. 2023. PBX1-promoted SFRP4 transcription inhibits cell proliferation and epithelial-mesenchymal transition in endometrial carcinoma. In Tissue & cell, 82, 102083. doi:10.1016/j.tice.2023.102083. https://pubmed.ncbi.nlm.nih.gov/37054536/
6. Mashhadikhan, Maedeh, Kheiri, Hamidreza, Dehghanifard, Ali. 2020. DNA methylation and gene expression of sFRP2, sFRP4, Dkk 1, and Wif1 during osteoblastic differentiation of bone marrow derived mesenchymal stem cells. In Journal of oral biosciences, 62, 349-356. doi:10.1016/j.job.2020.08.001. https://pubmed.ncbi.nlm.nih.gov/32835781/